Skip to content
10-Q

Quarterly Report

NEUROMIND AI CORP.

0001213900-24-066269

← back to feed
Filed
Aug 8, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$343.69K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$143.2K
Cash And Equivalents Q1 2024 · Mar 31, 2024 $0
Cash And Equivalents Q1 2024 · Dec 31, 2023 $0
Stockholders Equity Q1 2024 · Mar 31, 2024 −$5.52M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$5.24M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$4.26M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$17.91M
Total Liabilities Q1 2024 · Mar 31, 2024 $5.62M
Total Liabilities Q1 2024 · Dec 31, 2023 $5.34M
Total Assets Q1 2024 · Mar 31, 2024 $1.06M
Total Assets Q1 2024 · Dec 31, 2023 $1.05M
Sga Expense Q1 2024 · Mar 31, 2024 $30K
Sga Expense Q1 2024 · Mar 31, 2023 $30K
Net Income Q1 2024 · Mar 31, 2024 −$267.51K
Net Income Q1 2024 · Mar 31, 2023 $1.35M
Operating Income Q1 2024 · Mar 31, 2024 −$281.15K
Operating Income Q1 2024 · Mar 31, 2023 −$264.01K
Stock Repurchased Q1 2024 · Mar 31, 2023 $263.33M